select search filters
briefings
roundups & rapid reactions
before the headlines
Fiona fox's blog

Tag search results

expert reaction to two studies reporting results on monitoring prostate cancer versus surgery or radiotherapy, and survival and cancer progression

Two studies published in the New England Journal of Medicine reported that in men with localised prostate cancer (that hadn’t spread) active monitoring was not significantly more dangerous than surgery or radiotherapy in terms of survival, and that surgery and radiotherapy reduce the risk of cancer progression compared with active monitoring but can also cause more unpleasant side-effects including sexual or bowel impairment. read more

expert reaction to two posters being presented at the European Obesity Summit, one on bariatric surgery for type 2 diabetes and estimated NHS cost saving*, and one on mortality in obese people that have surgery versus those that don’tǂ

Two posters at the European Obesity Summit have presented results on bariatric surgery, with one reporting its financial and health benefits when applied to type 2 diabetes, and another reporting lower mortality for obese individuals who undergo the surgery. read more

expert reaction to statement on surgical intervention in the treatment of type 2 diabetes

New guidelines published in the journal Diabetes Care recommend that surgery be considered a standard option for appropriate candidates with type 2 diabetes, including in mildly obese people, and they call for health care regulators to introduce appropriate reimbursement policies. To date guidelines have been formally endorsed by 45 worldwide medical and scientific societies. read more

type 2 diabetes becomes an operable disease

A Joint Statement by leading diabetes organizations including the American Diabetes Association (ADA), Diabetes UK, International Diabetes Federation (IDF), Chinese Diabetes Society and Diabetes India and endorsed by 45 worldwide scientific societies, formally recognize surgery as a standard treatment option for type 2 diabetes. This development may be one of the biggest and most significant changes in diabetes care since the introduction of insulin in 1920s. Obesity guidelines have recommended for years bariatric surgery for people with severe obesity including many with associated diabetes. It is the first time, however, that diabetes guidelines recommend surgery as a treatment option for the management of the disease itself. read more

expert reaction to study on the use of PET-CT scans to detect remaining cancer cells in neck and head cancer patients

The practice of neck dissection in the treatment of advanced head and neck cancer has been associated with complications for some patients. A randomised trial published in the New England Journal of Medicine reports that neck dissection is avoidable in 80% of cases and that the alternative application of PET-CT guided surveillance has similar survival rates and is more cost-effective. read more

expert reaction to evidence for human transmission of amyloid-Beta

Publishing in the journal Nature, a group of researchers has described their autopsy examination of eight individuals with CJD which was caused by treatment with “human cadaveric pituitary-derived growth hormone contaminated with prions” earlier in life. They report the presence of markers of Alzheimer’s disease in a number of cases and suggest that this may also be due to the treatment with contaminated hormone. read more

Surgical Outcomes Data – what are we to make of it?

This summer the surgical profession will for the first time begin publishing data around the individual performance of surgeons across a wide range of operations. Data on such a large scale present huge challenges along with the obvious benefits, so this briefing allowed science and health journalists to get to grips with some of the complexities of this new system before its introduction. read more

colorectal cancer

Colorectal cancer is the third most frequently diagnosed cancer worldwide, and a major cause of death, but the value of screening programmes continues to be a source of much debate. In new research published in The Lancet, researchers have announced the findings of a UK-based trial, which started 16 years ago, to assess the merit of a single sigmoidoscopy lower bowel examination in patients aged 55-64 years to screen for colorectal cancer. read more

search by tag

see the latest